Understanding the origins of Hodgkin lymphoma cells could lead to better diagnostics
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Understanding the origins of Hodgkin lymphoma cells could lead to better diagnostics
Discovery of a novel vulnerability in aggressive lymphoma could change future therapy
New scoring tool shows radiation can reprogram pancreatic tumour environment
The beating of the heart suppresses growth in cardiac cancers
FLAG-based regimen delivers strong outcomes in subtype of acute myeloid leukaemia
New targeted therapy shows promise against aggressive childhood and adult cancers
AACR 2026: Researchers define a mechanism‑driven strategy for targeting p53‑mutant cancers
Exploiting a new vulnerability that targets 'zombie’ cells as an anticancer therapy
Researchers teach AI to spot cancer risk by squeezing individual breast cells
Cancer during pregnancy has lasting psychological impact on the wellbeing of women
Extra sets of chromosomes may help aggressive tumour cells spread, study finds
Tovorafenib approved in the EU as the first targeted therapy in relapsed or refractory paediatric low-grade glioma regardless of BRAF alteration